Skip to content
City Confidential
 
Sorting the Bulls from the Bears - Tips & Insight into the UK Stock Markets
  • Home
  • Markets
    • Main Market
    • AIM Market
  • Penny Share Picks
  • The Trader
  • Newsletter
  • Portfolios
    • Trader Portfolio
  • Insight & Ideas
  • More
      • Lost Password?
    • Search
    • Follow us:
    • Twitter
    • Email
    • More
    • Menu
    City Confidential
     
    Sorting the Bulls from the Bears - Tips & Insight into the UK Stock Markets
    • Search
    AIM Market Free Tip

    Looking through the keyhole at SURGICAL INNOVATIONS – 2.4p

    by Simon Flather10 March 202117 March 2021
    • Share
    • Tweet
    • Pin it
    • Share
    • Email
    • More

    Almost all companies have been affected by the coronavirus pandemic and AIM-listed Surgical Innovations is no exception. The suspension of all non-urgent surgical procedures by the NHS in mid-March, in anticipation of a surge in hospital admissions due to COVID-19, had a significant impact on the company as its products are used in minimally invasive (or keyhole) surgery. However, the group was quick to take action to meet this challenge with most staff being furloughed and those that remained taking short-term salary reductions.  The company also restructured its banking facilities to provide sufficient headroom to get through the crisis.

    Surgical Innovations specialises in the design and manufacture of high-quality medical products, primarily for use in minimally invasive surgery.  These are sold in the UK through its subsidiary Elemental Healthcare and exported through a network of overseas distribution partners.  Elemental also distributes complementary products from third party manufacturers in the UK and these are used in laparoscopy, hernia repair and breast reconstruction.  The company also designs and develops medical devices for carefully selected OEM partners and has also provided precise engineering solutions to a major UK industrial partner outside the medical arena.

    Although the results for the six months to 30 June 2020 saw revenues almost halve to £2.6m compared with a year earlier, with a significant loss being recorded, the group has seen its trading recover more quickly than first expected.  After the announcement of the interim results in September, the group also took the opportunity to raise £2.05m (after expenses) through a placing and open offer at 1.6p per share.

    Related

    • Wake up to eve Sleep! eve Sleep (EVE) – 5.35p

    In the most recent trading update issued in December, the company reported that revenues had recovered strongly in the second half of the year with full year revenue for 2020 expected to exceed £6.0m.  Helped by the fundraising, net cash at 30 November was £3.38m.

    The company has not been resting on its laurels whilst coping with the crisis though.  It has launched new products, whilst it has also extended its distribution network in the US with two new agreements being signed which will provide a significant opportunity for the group to grow its presence in this important market.

    Annual results for 2020 are due to be announced on 25 March and, whilst these are not likely to be very good, there will clearly be an update on trading which we hope will be positive. As the world begins to return to some sort of normality the company is well-placed to benefit and we believe the shares merit a recommendation of BUY.

     

    RECENT TIPS – The highs and the lows

    For a flavour of our performance recently, we list below some of our recommendations that we have made in the last few weeks.

    Lloyds Banking Group – 41.14p at close on 9 March (tipped at 33.91p on 25 January) – gain of 21%.

    *Shares in the bank had fallen to a level where we thought there was a good short-term trading opportunity.

    Duke Royalty – 36p at close on 9 March (tipped at 29,75p on 16 February) – gain of 21%.

    *Recent positive news flow had not been reflected in the share price

    DX Group – 27.5p at close on 9 March (tipped at 30.5p on 2 March) – a loss of 10%.

    *The interim results announced on 2 March showed a strong recovery in trading

     

    Read about some of our other recent top performing share tips, here.

    Tagged: AIM Market aim share tips Free AIM share tips Pharmaceuticals & Biotechnology SUN

    Related Stories

    • Wake up to eve Sleep! eve Sleep (EVE) – 5.35p

      7 April 2021
    • Get well equipped with HSS HIRE (HSS) – 16.85p

      31 March 2021
    • Surgical Innovations – 2.6p

      25 March 2021
    • cityconfidential Newsletter March 2021

      25 March 202125 March 2021
    • A chance to clean up with BYOTROL (BYOT) – 5.7p

      24 March 202125 March 2021
    • Surgical Innovations – 2.8p

      22 March 2021
    • Fortune favours the Brave? Focus on BRAVE BISON – 1.3p

      17 March 202119 March 2021
    • cityconfidential Newsletter February 2021

      18 February 202118 February 2021

    Post navigation

    Previous Story TT Electronics – 211p
    Next Story Coral Products – 11.75p

    Market Indices

    Watching

    News

    • Main Market
    • AIM Market
    • Penny Stocks
    • The Trader

    About

    • Contact
    • T&Cs
    • Privacy
    • Wealth Warning

    Membership

    • Subscribe
    • Your Account

    01943 600 644  |  info@cityconfidential.co.uk
    1 Skipton Road, Ilkley, West Yorkshire, LS29 9EH

    Please note, live feed data is subject to a 15 minute delay.

    © Independent Financial Publications. All Rights Reserved. | Westbrook Agency
    City Confidential
     
    Sorting the Bulls from the Bears - Tips & Insight into the UK Stock Markets
    • Subscribe
    • Your Membership
    • Home
    • Newsletter
    • Main Market
    • AIM Market
    • Penny Share Picks
    • The Trader
    • Trader Portfolio
    • Insight & Ideas
    • Contact
    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled

    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

    Non-necessary

    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

    SAVE & ACCEPT